Abstract 3821: Clinical utility of a urine-based urothelial cancer test in equivocal upper tract lesions: improving malignancy detection and minimizing unnecessary URS
Paolo Piatti, Christian D. Fankhauser(University of Zurich), A. Mattei(Luzerner Kantonsspital), Philipp Baumeister(University of Lucerne), Kilian Röthlin(University of Basel), Yap Ching Chew(Orange County Research Center), Farah Toullier-Garcia(Orange County Research Center), Ernest Kaufmann(University of Lucerne)
Cited by 0
Related Papers
Frequent PD-L1 expression in testicular germ cell tumors
|British Journal of Cancer|2015|172
Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
|Oncotarget|2017|57
Protein Kinase C (PKC) δ Suppresses Keratinocyte Proliferation by Increasing p21Cip1 Level by a KLF4 Transcription Factor-dependent Mechanism
|Journal of Biological Chemistry|2011|54
Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples
|Clinical Epigenetics|2021|45